Mglieduo Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
MFDS item code 202201733 · Approved 2022.04.28
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with dietary and exercise therapy to assist in blood sugar control in adult patients with type 2 diabetes through the combined administration of empagliflozin and metformin. In particular, in type 2 diabetes patients whose blood sugar control is inadequate and who have cardiovascular disease, the impact on the occurrence of cardiovascular events should refer to professional information. This medication helps to effectively manage blood sugar for diabetes treatment.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each ingredient: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines, such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and their current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; skip the missed dose in this case. Special Populations Patients with Renal Impairment No dose adjustment is needed for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
This medication aids in blood sugar control. However, caution is advised as it may cause a rare side effect called severe lactic acidosis. When used with other diabetes medications, there is a risk of hypoglycemia. Patients with moderate to severe renal impairment, acute renal issues, severe infection, or heart failure should not use this medication due to potential risks. It should be temporarily discontinued before and after tests using iodine contrast agents and can be restarted only after renal function is confirmed to be normal. Patients scheduled for surgery should also discontinue this medication 48 hours prior to surgery and wait until renal function returns to normal post-surgery. Pregnant women or those who may become pregnant, as well as nursing mothers, should not use this medication for safety reasons. This medication may be affected by renal function, therefore renal function should be monitored regularly during use. Additionally, irregular meals, intense exercise, and interactions with other medications may increase the risks of hypoglycemia or lactic acidosis, so caution is needed. This medication may lead to side effects such as urinary tract infections or genital infections, and symptoms should prompt consultation with a physician. Long-term use may cause vitamin B12 deficiency, hence blood tests are recommended to monitor this. Alcohol consumption may increase the risk of lactic acidosis, therefore excessive drinking should be avoided while taking this medication. In elderly patients, there is a higher risk of fluid loss, so enhanced caution is needed, along with dosage adjustments based on renal function. In case of overdose, it is essential to visit a medical institution immediately for appropriate treatment, which may include hemodialysis. This medication has not been established for safety and efficacy in children, hence is not recommended for those under 18 years of age. Lastly, this medication should be stored out of reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container, protected from air and moisture, at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain its effectiveness.
Brownish yellow, oval film-coated tablet with a convex shape on both sides
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.